Julie O’Neill, Alexion’s EVP for Global Operations highlights Alexion’s establishment of its Global Supply Chain headquarters in Dublin, Ireland, its investment in Athlone, her thoughts on the opportunities and challenges in the Irish pharmaceutical landscape, and her vision for Alexion.
Alexion first established a manufacturing presence in Dublin, Ireland in 2013 followed by the acquisition of the Athlone vialing facility for EUR 55 million in 2014. What was the rationale behind this expansion?
Our goal is always to deliver for patients – we cannot put ourselves in a situation where we are unable to meet our patients’ demand for our therapies in ultra-rare diseases.
